Spectral Medical Inc. (TSE:EDT – Get Free Report) shares passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$1.38 and traded as high as C$1.38. Spectral Medical shares last traded at C$1.33, with a volume of 32,395 shares.
Spectral Medical Stock Performance
The company has a debt-to-equity ratio of 26.03, a quick ratio of 0.45 and a current ratio of 0.61. The company has a market cap of C$396.12 million, a PE ratio of -10.38 and a beta of 0.82. The business’s 50-day moving average is C$1.38 and its 200 day moving average is C$1.36.
Spectral Medical (TSE:EDT – Get Free Report) last released its quarterly earnings data on Friday, May 8th. The company reported C($0.01) EPS for the quarter. The firm had revenue of C$0.89 million during the quarter. On average, equities research analysts predict that Spectral Medical Inc. will post -0.05 EPS for the current fiscal year.
About Spectral Medical
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The segments of the group are Spectral Medical Inc, which is the key revenue-generating segment that manufactures and sells its EAA diagnostic and certain proprietary reagents; Dialco Medical Inc segment; and Corporate.
Further Reading
- Five stocks we like better than Spectral Medical
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
